Mankind Pharma Ltd. Financials: Quarterly Results

Revenue 3330.7 Cr.

PAT 426.67 Cr.

EBITDA 703.65 Cr.

Mankind Pharma Ltd. Q4FY25 Financial Metrics

IndicatorMar-25Dec-24Sep-24Jun-24Mar-24
Net Sales/Income from operations (Cr.)3079.3732303076.512893.422441.10
Total Income From Operations (Cr.)3079.3732303076.512893.422441.10
P/L Before Interest, Excpt. Items & Tax (Cr.)703.65714.82853.85674.62578.54
P/L Before Exceptional Items & Tax (Cr.)513.11493.89846.75663.71569.16
P/L After Tax from Ordinary Activities (Cr.)426.67381.08656.31539.16474.18
Net Profit/Loss For the Period (Cr.)422.33381.08656.31539.16474.18
Basic EPS10.209.4516.3113.3911.76

Open FREE Demat Account

+91

By proceeding, you agree to the T&C.

hero_form

FAQs

Mankind Pharma Ltd. announced its quarterly results for Q4 FY2025 on May 21, 2025.

In Q4 FY2025, Mankind Pharma Ltd. are as follows:
Revenue: ₹3330.7 crore
Net Profit: ₹422.33 crore.

For Q4 FY2025, Mankind Pharma Ltd. posted ₹3330.7 crore in revenue and ₹422.33 crore in net profit.

Past quarterly results for Mankind Pharma Ltd. can be found on their official Investor Relations page, which includes detailed reports and financial performance summaries.

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form